CHERUVU PAVAN (Chief Executive Officer) purchased 124.3% of their position (100K shares) of SIO GENE THERAPIES INC. on the open market
Open‑market purchase worth $248.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/24/2021ACC: 0001636050-21-000033
DirectorOfficer· Chief Executive Officer
Since Apr 2019
+100K
Net shares
Net buyer
$248.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$2.48
Trade value
$248.18K
% of position
124.3%
3/23/2021
80.43K→180.43K
Total
Net shares
+100K
Net value
$248.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/23/2021 | P · Purchase | +100K | $2.48 | $248.18K | 124.3% | 80.43K | 180.43K |
| Total | +100K | $248.18K | ||||||
Derivative Transactions0
No derivative transactions reported